Symbol: EKO / TSX

>>

MONTREAL, Aug. 11 /CNW Telbec/ - Noveko International Inc. ("the

Company") is pleased to announce that further to the preliminary discussions

previously announced on March 24, 2009, its subsidiary Noveko Trading 2008 LLC

("Noveko Trading") has entered into a License and Supply Agreement with

Microban International, Ltd. ("Microban"), the global leader in built-in

antimicrobial product protection, engineering durable antimicrobial solutions

for consumer, industrial and healthcare products around the world.

Under the terms of this agreement, Microban has granted Noveko the right

to sell its line of AZURO(TM) hand sanitizers under the Microban(R) brand

name. This global agreement also grants Noveko the right to use the Microban

brand as the lead/host brand or ingredient brand, and the right and licence to

use the Microban antimicrobial technology and Microban's proprietary

antimicrobial additives, in the manufacture of the Noveko's surgical masks and

respirators through December 31, 2012.

"We have made a crucial strategic decision by choosing Microban as a

partner. Through this agreement, we will gain access to the expertise and

reputation of a worldwide leader in the antimicrobial market which will allow

us to optimize our products - both in performance and in cost. Combining the

AZURO(TM) hand sanitizer quality and performance with the Microban brand name

will further accelerate our global market penetration in all segments,"

indicated Alain Bolduc, President and Chief Operating Officer of the Company.

David Meyers, President and CEO of Microban International says, "Microban

antimicrobial technology provides a strong benefit for these product

applications and we are happy to partner with Noveko to bring a range of

innovative new products to market under the Microban brand name, especially

during a time when consumer concerns about the presence of microbes are

extremely high."

Profiles

Microban International, Ltd. is a global technology and marketing company

dedicated to enhancing high quality consumer, industrial and healthcare

products with branded built-in protection from microbes. Microban

International licenses the Microban (R) global brand name, sells

custom-engineered compounds, and provides a range of services, including

regulatory and marketing support. The Microban (R) brand promises continuous

and durable antimicrobial product protection, built-in during manufacture to

not wear out for the useful life of the product. Microban International is

headquartered in North Carolina with operations in North America, Europe and

Asia. For more information on Microban, please contact (704) 875-0806 or visit

www.microban.com.

Noveko International Inc. offers innovative solutions in the

environmental and medical fields worldwide. Through its subsidiaries, the

Company specializes primarily in the following business segments: the

development, manufacturing and marketing of derivative products from its

patented antimicrobial filtration technology, including air filters, surgical

masks and respirators, along with other products with antimicrobial properties

such as AZURO (TM) hand sanitizers - and the development, manufacturing and

marketing of medical equipment, primarily portable real-time ultrasound

scanners for use in human and veterinary medicine.

Certain statements set forth in this press release constitute

forward-looking statements. In some cases, these statements are identified by

the use of terms such as "may", "could", "might", "intend", "should",

"expect", "project", "plan", "believe", "estimate" or other comparable

variants. These statements are based on the information available at the time

they are written, on assumptions made by management and on the expectations of

management, acting in good faith, regarding future events, including those

relating to economic conditions, fluctuations in exchange rates and operating

expenses, and the absence of unusual events entailing supplementary

expenditures. Although management considers these assumptions and expectations

reasonable based on the information available at the time they are written,

they could prove inaccurate. Forward-looking statements are also subject, by

their very nature, to known and unknown risks and uncertainties such as those

related to the industry, acquisitions, labor relations, credit, key officers,

supply and product liability. The actual results of Noveko International Inc.

could differ materially from those indicated or underlying these

forward-looking statements. The reader is therefore recommended not to unduly

rely on these forward-looking statements. Forward-looking statements do not

reflect the potential impact of special items, any business combination or any

other transaction that may be announced or occur subsequent to the date

hereof. The Company undertakes no obligation to update or revise the

forward-looking statements to account for new events or new circumstances,

except where provided for by applicable legislation.

-30-

/For further information: Chantal Vennat, Director, Investor Relations

and Corporate Communications, Noveko International Inc., (514) 875-0606;

http://www.noveko.com/